0001193125-26-175965.txt : 20260424 0001193125-26-175965.hdr.sgml : 20260424 20260424112711 ACCESSION NUMBER: 0001193125-26-175965 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260422 FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lu Peng CENTRAL INDEX KEY: 0001972159 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 26891471 MAIL ADDRESS: STREET 1: C/O PHARVARIS N.V. STREET 2: EMMY NOETHERWEG 2, 2333 BK LEIDEN CITY: LEIDEN STATE: P7 ZIP: 2333 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN PROVINCE COUNTRY: P7 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN PROVINCE COUNTRY: P7 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 4 1 ownership.xml 4 X0609 4 2026-04-22 0001830487 Pharvaris N.V. PHVS 0001972159 Lu Peng false 1 CRANBERRY HILL SUITE 400 LEXINGTON MA 02421 false true false false Chief Medical Officer true Common Stock 2026-04-22 4 M false 7001 2.59 A 73084 D Common Stock 2026-04-22 4 S false 7001 30.0531 D 66083 D Common Stock 2026-04-23 4 M false 100 2.59 A 66183 D Common Stock 2026-04-23 4 S false 100 30.0300 D 66083 D Stock Option (Right to Buy) 2.59 2026-04-22 4 M false 7001 0 D 2030-02-03 Common Stock 7001 106307 D Stock Option (Right to Buy) 2.59 2026-04-23 4 M false 100 0 D 2030-02-03 Common Stock 100 106207 D This is a scheduled exercise and sale from 10b5-1 trading plan. These shares were sold in multiple transactions at prices ranging from $30 - $30.15. These shares were sold in multiple transactions at prices ranging from $30.03 - $31.0299. 25% of the option vested on February 3, 2020 with the remaining shares vesting in 1/48 monthly installments thereafter. /s/ Marnus Nel, Attorney-in-Fact for Peng Lu 2026-04-24